News
Covidien Announces Launch of Puritan Bennett(TM) 520 Portable Ventilator
Covidien, a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced that the Puritan Bennett(TM) 520 ventilator is now available in the European Union. The Puritan Bennett...
News
Mylan Receives Approval for Generic Version of Precose Tablets
Mylan Inc.announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Acarbose Tablets, 25 mg, 50 mg and 100 mg, the generic...
News
Boehringer Ingelheim to Purchase Amgen’s Fremont Facility
Amgen Inc. and Boehringer Ingelheim announced they have signed an agreement under which Boehringer Ingelheim will acquire Amgen's rights in and substantially all assets at Amgen's Fremont California development and manufacturing facility. The transaction has been...
News
European Commission Clears Acquisition of Gensyme Corporation by sanofi-aventis
Sanofi-aventis announced that the European Commission has cleared sanofi-aventis' proposed acquistion of Genzyme corporation unconditionally under EU merger control rules. Sanofi-aventis welcomes this decision, which is a requisite step in satisfaction of the condition to the...
News
Shionogi Inc announced availabilty of Kapvay
Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., announced a true milestone as it marks the first commercial availability for the noncentral nervous system stimulant medication KAPVAY, an extended-release oral formulation of clonidine for Attention Deficit...
News
Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, announced the launch of the latest addition to their premier line of next-generation imaging products, the FluorChem® M MultiFluor system. This...
News
FDA extend review timeline for vandetanib new drug application
AstraZeneca announced that the US Food and Drug Administration (FDA) has extended the time to complete its review of the New Drug Application (NDA) for the investigational drug vandetanib. Â As part of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
